Novavax Earnings Call Reveals Surprise Profit, But Stocks Still Slide
It’s not the only vaccine producer struggling to get by, but Novavax looked terminal earlier this year by its own admission.
Stay updated with breaking news from John Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It’s not the only vaccine producer struggling to get by, but Novavax looked terminal earlier this year by its own admission.
Novavax is working to strengthen its financial position after it raised doubts about its ability to stay in business earlier this year.
Shares of Novavax (NASDAQ:NVAX) jumped Tuesday after the COVID vaccine maker reported a surprise second-quarter profit. The results come as Novavax works to strengthen its financial position, particularly after it raised doubts about its ability ...
Shares of Novavax Inc (NASDAQ: NVAX) after reported Q2 revenue of $424 million, compared to $186 million a year ago, beating the
Shares of Novavax (NASDAQ:NVAX) jumped Tuesday after the COVID vaccine maker reported a surprise second-quarter profit. The results come as Novavax works to strengthen its financial position, particularly after it raised doubts about its ability ...